Search

everythinglearnresearchcommunity

for

Search:↓

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

The woman was diagnosed with lichen planopilaris and can be treated with corticosteroids.

A child had a rare case of scarring hair loss with skin disease, which is hard to treat and stressful.

A new treatment using AGED to modulate PPAR-γ shows promise for treating scarring hair loss by protecting and repairing hair follicle cells.

Spironolactone safely and effectively treats hair loss in female scarring alopecia patients.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

The main difference in hair loss for lupus patients is smaller and fewer sebaceous glands.

CCCA is a common scarring hair loss in African descent women, possibly linked to genetics, hair care practices, and health issues like diabetes.

Seven patients were misdiagnosed with discoid lupus instead of lichen planopilaris due to similar symptoms, showing the need for careful diagnosis in scarring hair loss conditions.

Certain diets may help with hair growth in people with different types of hair loss.

Hair restoration surgery can potentially treat primary scarring alopecias, but it's important to start early medication, ensure patient remission before transplant, and monitor after surgery.

People with Alopecia Areata are more likely to have autoimmune diseases, inflammatory diseases, and mental health issues like anxiety and depression.

People with hair loss conditions often have more mental health issues like depression and anxiety compared to those without hair loss.

A young man's hair loss was the only sign of syphilis, which improved after treatment.

Minoxidil and finasteride are the best for non-scarring hair loss; more research is needed for scarring hair loss treatments.

Seborrhoeic dermatitis may cause a condition called "seborrhoeic folliculitis," leading to chronic scalp inflammation and scarring hair loss.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Regenerative cellular therapies show promise for treating non-scarring hair loss but need more research.

New digital tools are improving the diagnosis and understanding of irreversible hair loss conditions.

The most effective way to diagnose non-scarring hair loss is by transverse sectioning, and some cases, particularly in males with inflammation around hair follicles, might be curable.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

Hair loss in androgenetic alopecia may be due to ongoing tiny inflammation and tissue changes around hair follicles.

Vitamin D deficiency is common in people with certain types of hair loss, like alopecia areata and female pattern hair loss.

Trichoscopy is a quick, accurate, and non-invasive method to diagnose and treat non-scarring hair loss.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Higher levels of β-carotene and vitamin E may help prevent certain types of hair loss.

The study found that alopecia areata and hypothyroidism increase the risk of each other, but androgenetic alopecia and hypothyroidism do not.

People with non-scarring hair loss often have lower vitamin D levels than those without hair loss.

Low iron levels are linked to hair loss in women.

Hair loss due to scarring can be treated by reducing inflammation, removing scar tissue, and transplanting hair. The Follicular Unit Extraction technique is effective but requires skill and time. Future focus should be on scar-less healing methods.